Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology
2020 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Pudil, R., Mueller, C., Čelutkienė, J., Henriksen, P. A., Lenihan, D., Dent, S., Barac, A. ... Lyon, A. R. (2020). Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology. European Journal of Heart Failure, 22(11), 1966-1983. doi: https://doi.org/10.1002/ejhf.2017
Documents & Media
Details
- Authors
- Pudil, Radek; Mueller, Christian ; Čelutkienė, Jelena; Henriksen, Peter A.; Lenihan, Dan; Dent, Susan; Barac, Ana; Stanway, Susanna; Moslehi, Javid; Suter, Thomas M.; Ky, Bonnie; Štěrba, Martin; Cardinale, Daniela; Cohen‐Solal, Alain; Tocchetti, Carlo Gabriele; Farmakis, Dimitrios; Bergler‐Klein, Jutta; Anker, Markus S.; Von Haehling, Stephan ; Belenkov, Yury; Iakobishvili, Zaza; Maack, Christoph; Ciardiello, Fortunato; Ruschitzka, Frank; Coats, Andrew J.S.; Seferovic, Petar; Lainscak, Mitja; Piepoli, Massimo F.; Chioncel, Ovidiu; Bax, Jereon; Hulot, Jean‐Sebastien; Skouri, Hadi; Hägler‐Laube, Eva Simona; Asteggiano, Riccardo; Fernandez, Teresa Lopez; Boer, Rudolf A.; Lyon, Alexander R.
- Issue Date
- 2020
- Journal
- European Journal of Heart Failure
- ISSN
- 1388-9842
- eISSN
- 1879-0844
- Language
- English